政府:复必泰现包装瑕疵或由运输环境引致 无证据显示疫苗存安全风险
政府公布,早前卫生署发现复必泰疫苗累计多宗包装瑕疵,已即时通报疫苗供应商并要求立刻跟进,根据复星及BioNTech到目前为止所完成的调查,并未发现疫苗由封装到使用的过程中,有任何可能造成相关包装瑕疵的显着系统性因素。现阶段调查结果不排除有关情况是由长途运输过程中环境因素所引致。然而综合调查所得数据,相信出现有关情况并非与冷链及物流管理有关。至於其余已抵港的疫苗,经随机抽样测试包装完整的疫苗药瓶,亦并未发现疫苗渗漏的问题。
根据初步调查结果,复星与德国药厂BioNTech认为没有证据显示已抵港的复必泰疫苗存在安全风险,已接种复必泰疫苗的市民无需担心,後续调查工作主要以查证相关疫苗批次并无任何固有特性问题而可继续安全使用为目标。
政府正与复星和德国药厂BioNTech积极跟进,争取在一周内完成调查程序,并会与供应商就余下疫苗供应保持密切联系,确保本港疫苗接种计划能够持续。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.